Palvella Therapeutics (PVLA) EBT Margin Growth (3y) (2017 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,297.00 |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -474,601.00 |
| Sep 30, 2023 | 36,811.00 |
| Jun 30, 2023 | 5,298.00 |
| Mar 31, 2023 | -75,608.00 |
| Sep 30, 2022 | -460,574.00 |
| Jun 30, 2022 | -13,121.00 |
| Mar 31, 2022 | 5,321.00 |
| Dec 31, 2021 | 175,268.00 |
| Sep 30, 2021 | -60,927.00 |
| Jun 30, 2021 | -65,676.00 |
| Mar 31, 2021 | 17,098.00 |
| Dec 31, 2020 | -70,285.00 |
| Sep 30, 2020 | -26,438.00 |
| Jun 30, 2020 | 46,008.00 |
| Mar 31, 2020 | 56,856.00 |
| Dec 31, 2019 | 20,938.00 |
| Sep 30, 2019 | 77,219.00 |
| Jun 30, 2019 | 32,785.00 |
| Mar 31, 2019 | 21,268.00 |
| Dec 31, 2018 | -262,125.00 |
| Sep 30, 2018 | 86,252.00 |
| Jun 30, 2018 | 219,989.00 |
| Mar 31, 2018 | 149,250.00 |
| Sep 30, 2017 | 1.06 Mn |
| Jun 30, 2017 | -8,762.00 |